(Q44073512)

29 November 2017

title

Anti-inflammatory effects of enteral diet components on Crohn's disease-affected tissues in vitro (English)

1 reference

29 November 2017

0 references

1 reference

D Meister

1 reference

29 November 2017

J Bode

series ordinal

1 reference

29 November 2017

A Shand

series ordinal

1 reference

29 November 2017

S Ghosh

series ordinal

1 reference

29 November 2017

publication date

1 June 2002

1 reference

Digestive and Liver Disease

29 November 2017

published in

1 reference

29 November 2017

1 reference

29 November 2017

1 reference

29 November 2017

page(s)

430-438

1 reference

Crohn's disease: nutrition and nutritional therapy

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980041-X

7 January 2021

A CONTROLLED THERAPEUTIC TRIAL OF VARIOUS DIETS IN ULCERATIVE COLITIS

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980041-X

7 January 2021

Ten years' experience with an elemental diet in the management of Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980041-X

7 January 2021

Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease: elemental versus polymeric diet

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980041-X

7 January 2021

Alterations in nutritional status and disease activity during treatment of Crohn's disease with elemental diet

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980041-X

7 January 2021

Nutrition in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980041-X

7 January 2021

Enteral nutrition in inflammatory bowel disease of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980041-X

7 January 2021

Supplementary enteral nutrition maintains remission in paediatric Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980041-X

7 January 2021

Oral nutritional supplementation is effective in the maintenance of remission in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980041-X

7 January 2021

Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980041-X

7 January 2021

Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980041-X

7 January 2021

Imbalance of the interleukin 1 system in colonic mucosa—association with intestinal inflammation and interleukin 1 receptor agonist genotype 2

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980041-X

7 January 2021

Role of interleukin 1 in inflammatory bowel disease--enhanced production during active disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980041-X

7 January 2021

Colonic explant production of IL-1and its receptor antagonist is imbalanced in inflammatory bowel disease (IBD).

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980041-X

7 January 2021

Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980041-X

7 January 2021

Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980041-X

7 January 2021

Immunohistochemical detection of abnormal cell proliferation in colonic mucosa of subjects with polyps

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980041-X

7 January 2021

Relationship of interleukin-1 receptor antagonist to mucosal inflammation in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980041-X

7 January 2021

Influence of interleukin-10 on the interleukin-1 receptor antagonist/interleukin-1 beta ratio in the colonic mucosa of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980041-X

7 January 2021

IL-10 secretion and sensitivity in normal human intestine and inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980041-X

7 January 2021

Modulation of immune responses by bovine beta-casein

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980041-X

7 January 2021

Modulation of immune function by a modified bovine whey protein concentrate

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980041-X

7 January 2021

Selective induction of CD8+ T cell functions by single substituted analogs of an antigenic peptide: distinct signals for IL‐10 production

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980041-X

7 January 2021

Mucosal cytokine expression, cellular markers and adhesion molecules in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980041-X

7 January 2021

10.1016/S1590-8658(02)80041-X

Identifiers

DOI

1 reference

29 November 2017

1 reference